UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 257

Sortiert nach

Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium

Journal of the American Academy of Dermatology, 2016-01, Vol.74 (1), p.27-58

2016

Volltextzugriff (PDF)

Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0

Journal of the American Academy of Dermatology, 2012-11, Vol.67 (5), p.1025-1039

2012

Volltextzugriff (PDF)

SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss

Journal of the American Academy of Dermatology, 2016-12, Vol.75 (6), p.1268-1270

2016

Volltextzugriff (PDF)

Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study

Journal of the American Academy of Dermatology, 2020-02, Vol.82 (2), p.412-419

2020

Volltextzugriff (PDF)

Bridging the specialty gap: Update on primary cutaneous lymphomas

Journal of the American Academy of Dermatology, 2024-02, Vol.90 (2), p.257-260

2024

Volltextzugriff (PDF)

Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma

Dermatologic clinics, 2015-10, Vol.33 (4), p.643-654

Olsen, Elise A., MD

2015

Volltextzugriff (PDF)

Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

Journal of clinical oncology, 2007-07, Vol.25 (21), p.3109-3115

2007

Volltextzugriff (PDF)

Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University

Journal of the American Academy of Dermatology, 2013-05, Vol.68 (5), p.749-755

2013

Volltextzugriff (PDF)

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

Blood, 2007-07, Vol.110 (2), p.479-484

2007

Volltextzugriff (PDF)

Investigative guidelines for alopecia areata

Dermatologic therapy, 2011-05, Vol.24 (3), p.311-319

OLSEN, ELISE A.

2011

Volltextzugriff (PDF)

Objective outcome measures: Collecting meaningful data on alopecia areata

Journal of the American Academy of Dermatology, 2018-09, Vol.79 (3), p.470-478.e3

2018

Volltextzugriff (PDF)

Focal atrichia: A diagnostic clue in female pattern hair loss

Journal of the American Academy of Dermatology, 2019-06, Vol.80 (6), p.1538-1543.e1

2019

Volltextzugriff (PDF)

Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)

Journal of the American Academy of Dermatology, 2011-02, Vol.64 (2), p.352-404

2011

Volltextzugriff (PDF)

A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men

Journal of the American Academy of Dermatology, 2007-11, Vol.57 (5), p.767-774

2007

Volltextzugriff (PDF)

United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic

Journal of the American Academy of Dermatology, 2020-08, Vol.83 (2), p.703-704

2020

Volltextzugriff (PDF)

Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas

Modern pathology, 2017-05, Vol.30 (5), p.761-772

2017

Volltextzugriff (PDF)

Cutaneous Lymphoma

Dermatologic clinics, 2015-10, Vol.33 (4), p.i-i

2015

Volltextzugriff (PDF)

Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss

Journal of the American Academy of Dermatology, 2003-02, Vol.48 (2), p.253-262

Olsen, Elise A.

2003

Volltextzugriff (PDF)

The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride

Journal of the American Academy of Dermatology, 2006-12, Vol.55 (6), p.1014-1023

2006

Volltextzugriff (PDF)

Central centrifugal cicatricial alopecia: what has been achieved, current clues for future research

Dermatologic clinics, 2014-04, Vol.32 (2), p.173-181

2014

Volltextzugriff (PDF)

TGF-β contamination of purified recombinant GDF15

PloS one, 2017-11, Vol.12 (11), p.e0187349-e0187349

2017

Volltextzugriff (PDF)

Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides

JAMA dermatology (Chicago, Ill.), 2013-01, Vol.149 (1), p.25

2013

Volltextzugriff (PDF)

1 – 25 von 257

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(227)
Mit Volltextzugriff
(221)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Guidelines for phototherapy of mycosis fungoides and Sézary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium

Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0

SALT II: A new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss

Ruxolitinib cream for the treatment of patients with alopecia areata: A 2-part, double-blind, randomized, vehicle-controlled phase 2 study

Bridging the specialty gap: Update on primary cutaneous lymphomas

Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma

Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

Frontal fibrosing alopecia: A retrospective review of 19 patients seen at Duke University

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

Investigative guidelines for alopecia areata

Objective outcome measures: Collecting meaningful data on alopecia areata

Focal atrichia: A diagnostic clue in female pattern hair loss

Sézary syndrome: Immunopathogenesis, literature review of therapeutic options, and recommendations for therapy by the United States Cutaneous Lymphoma Consortium (USCLC)

A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men

EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

United States Cutaneous Lymphoma Consortium recommendations for treatment of cutaneous lymphomas during the COVID-19 pandemic

Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas

Cutaneous Lymphoma

Current and novel methods for assessing efficacy of hair growth promoters in pattern hair loss

The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride

Central centrifugal cicatricial alopecia: what has been achieved, current clues for future research

TGF-β contamination of purified recombinant GDF15

Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides

Suchergebnisse filtern